SEC Form 4 · accession 0001162194-15-000073
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mai Chan Yow
Officer — See Remarks
Period of report
Apr 8, 2015
Accepted (ET)
Apr 9, 2015 · 8:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 8, 2015 | M | 7,859 | $14.60 | A | 9,375 | D | |
| Common Stock | Apr 8, 2015 | M | 22,141 | $15.49 | A | 31,516 | D | |
| Common Stock | Apr 8, 2015 | S | 10,000 | $42.00 | D | 21,516 | D | |
| Common Stock | Apr 8, 2015 | S | 20,000 | $43.00 | D | 1,516 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $14.60 | Apr 8, 2015 | M | 7,859 | D | — | May 17, 2021 | Common Stock | 7,859 | 834 | D |
| Employee Stock Option (Right to Buy)F3 | $15.49 | Apr 8, 2015 | M | 22,141 | D | — | Feb 17, 2022 | Common Stock | 22,141 | 37,859 | D |
Explanation of responses
- F1The sales reported by Ms. Yow were effected pursuant to a Rule 10b5-1 trading plan adopted on March 3, 2015.
- F21/48th of the shares subject to the Option vested on June 18, 2011 and 1/48th of the shares subject to the Option vest each month thereafter, such that the Option will be fully vested on May 18, 2015.
- F31/48th of the shares subject to the Option vested on February 17, 2012 and 1/48th of the shares subject to the Option vested on March 1, 2012 and each month thereafter, such that the Option will be fully vested on January 1, 2016.
Remarks
EXECUTIVE VP, WORLDWIDE MANUFACTURING & MANAGING DIRECTOR - SINGAPORE